Innovative Diagnostics ID™ SARS-CoV-2 / Influenza Triplex RT-PCR

Triplex RT-PCR test allowing for the detection and differentiation of SARS-CoV-2 and Influenza A/B viruses in humans.

Qualitative triplex RT-PCR which simultaneously amplifies SARS-CoV-2, Influenza A and Influenza B target sequences and an endogenous internal control.

This test was developed by Innovative Diagnostics’ sister company: ID-Solutions, which is specialized in circulating DNA diagnostics in human oncology. The test is CE-IVD marked.

  • High sensitivity: LOD(95%) is < 12 copies/PCR
  • Positive Extraction Control (PEC): unique on the market, for the validation of the extraction process and reverse transcriptase step
  • Endogenous internal control to ensure sample presence and the absence of false negatives
  • Ready-to-use
  • Results are obtained within 1 hour
  • Validated on the main thermocyclers on the market


Method RT-PCR - Triplex - Qualitative
Species Humans
Sample types Nasopharyngeal, oropharyngeal swabs or sputum samples

vairāk informācijas...